Characteristics | PGK1 | ||
---|---|---|---|
Low expression | High expression | P-value | |
Age | 57.84 ± 12.81 | 58.77 ± 13.57 | 0.243 |
T stage | Â | Â | 0.002 |
 T1 | 156 | 124 |  |
 T2 | 304 | 331 |  |
 T3 | 77 | 62 |  |
 T4 | 10 | 29 |  |
 Tx | 1 | 2 |  |
N stage | Â | Â | 0.047 |
 N0 | 270 | 247 |  |
 N1 | 187 | 176 |  |
 N2 | 44 | 75 |  |
 N3 | 38 | 39 |  |
 Nx | 9 | 11 |  |
M stage | Â | Â | 0.007 |
 M0 | 453 | 457 |  |
 M1 | 4 | 17 |  |
 Mx | 91 | 74 |  |
Tumor stage (AJCC 8th version) | Â | 0.001 | |
 Stage I | 110 | 72 |  |
 Stage II | 309 | 315 |  |
 Stage III | 117 | 131 |  |
 Stage IV | 3 | 16 |  |
 Stage X | 6 | 6 |  |
 NA | 3 | 8 |  |
ER status | Â | Â | <Â 0.001 |
 Positive | 461 | 345 |  |
 Negative | 64 | 176 |  |
 NA | 23 | 27 |  |
PR status | Â | Â | <Â 0.001 |
 Positive | 410 | 288 |  |
 Negative | 113 | 232 |  |
 NA | 25 | 28 |  |
Her2 status | Â | Â | <Â 0.001 |
 Positive | 50 | 111 |  |
 Negative | 288 | 276 |  |
 NA | 210 | 161 |  |
Overall survival | Â | Â | <Â 0.001 |
 Alive | 495 | 453 |  |
 Dead | 53 | 95 |  |